VERIFY: A randomized controlled phase 3 study of the hepcidin mimetic rusfertide (PTG-300) in patients with polycythemia vera (PV).

• Authors: BANKAR Aniket; PETTIT Kristen; SHATZEL Joseph; YACOUB Abdulraheem; PEMMARAJU Naveen; GILL Harinder; HLUSI Antonin; LUCCHESI Alessandro; ALIMAM Samah; MAYER Jiří; PALANDRI Francesca; SASCA Daniel; MODELSKA Katharina; GUPTA Suneel K; AJARI Ifode; KHANNA Sarita; MOLINA Arturo; KUYKENDALL Andrew Tucker
• Year of publication: 2024
• Type: Conference abstract
• MU Faculty or unit: Faculty of Medicine